Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific...

Area of Science:

• Immunology
• Molecular Biology
• Drug Discovery

Background:

• Cytosolic DNA triggers innate immune responses via Stimulator of Interferon Genes (STING) signaling.
• STING activation enhances vaccine immunogenicity and anti-tumor therapies.
• Human STING protein exhibits allelic variants impacting drug response.

Purpose of the Study:

• To identify and characterize a novel agonist of human STING.
• To investigate the variant-specific activity of the novel STING agonist.
• To evaluate the potential of the STING agonist in simulating innate immune responses for adaptive immunity.

Main Methods:

• Synthesis and characterization of a novel small molecule, M04.
• In vitro assays using primary human cells and cells expressing human STING variants.
• Ex vivo analysis of M04's ability to induce cytokine secretion, dendritic cell maturation, and T cell cross-priming.

Main Results:

• M04 is identified as a novel agonist of human STING.
• M04 demonstrates differential activation of human STING variants.
• M04 is inactive in mice but active in human STING-expressing cells, and it stimulates key innate immune responses ex vivo.

Conclusions:

• M04 serves as a valuable research tool for studying STING biology.
• M04 shows potential as an immune-potentiating molecule for therapeutic applications.
• Understanding STING variant-specific activity is crucial for targeted drug development.